FNB Total Current Liabilities

F.N.B. Corporation Common Stock · Total Current Liabilities

FNB logo

FNB Total Current Liabilities

Latest reported$3.00B
FNB Quarterly Current Liabilities ($1.05B → $3.00B)
High-resolution chart · PNG

FNB total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

F.N.B. Corporation Common Stock Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
3,001,000,000
2,681,000,000
2,157,000,000
40,776,000,000
40,214,000,000
39,491,000,000
39,071,000,000
38,227,000,000
38,203,000,000
38,483,000,000
36,692,000,000
37,104,000,000
36,569,000,000
36,102,000,000
36,220,000,000
36,017,000,000
35,156,000,000
34,738,000,000
35,197,000,000
33,132,000,000
32,881,000,000
31,992,000,000
31,919,000,000
30,805,000,000
30,621,000,000
30,694,000,000
28,082,000,000
27,894,000,000
27,632,000,000
27,334,000,000
27,883,000,000
27,471,000,000
27,065,015,000
26,744,591,000
26,162,581,000
25,941,000,000
25,665,950,000
25,343,923,000
24,782,023,000
18,440,709,000
18,084,671,000
17,665,292,000
16,830,045,000
14,548,195,000
13,922,056,000
13,740,507,000
13,418,322,000
13,294,904,000
12,924,310,000
12,432,836,000
12,026,448,000
11,309,973,000
10,757,981,000
10,545,738,000
10,021,762,000
10,029,994,000
10,145,234,000
9,920,810,000
9,932,982,000
8,006,428,000
8,185,632,000
8,125,519,000
8,128,831,000
7,399,746,000
7,415,410,000
7,270,100,000
7,204,837,000
7,049,390,000
6,865,189,000
6,829,266,000
6,685,528,000
6,650,886,000
6,705,239,000
6,389,409,000
4,902,244,000
4,847,507,000
4,935,372,000
4,869,327,000
4,759,287,000
4,736,752,000
4,772,685,000
4,763,284,000
4,428,782,000
4,390,921,000
4,446,146,000
4,450,160,000
4,390,291,000
3,993,193,000
3,770,356,000
3,775,727,000
3,717,719,000
3,672,476,000
6,879,412,000
6,828,446,000
6,633,038,000
5,941,937,000
5,825,835,000
5,737,481,000
5,739,689,000
5,474,830,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.